Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib

Breast Cancer: Basic and Clinical Research

Original Research

Austin Miller¹  Saif Soniwala¹  Ellis G Levine¹  Thaer Khoury¹  Kazuaki Takabe¹  Tracy O’Connor¹  Amy P Early¹  Kristopher Attwood¹  Roby Antony Thomas²  Adam Brufsky²  Mateusz Opyrchal³  Matthew G Hanna⁴  Ajay Dhakal⁵ 

[1] Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA;Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA;Department of Medicine, Washington University in St. Louis, St. Louis, MO, USA;Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA;Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA;

关键词: Metastatic breast cancer;    everolimus;    palbociclib;    estrogen receptor-positive breast cancer;   

DOI  :  10.1177/1178223420944864

 received in 2020-04-08, accepted in 2020-07-02,  发布年份 2020

来源: Sage Journals

【 授权许可】

CC BY-NC   
© The Author(s) 2020

【 图 表 】

Figure 2.

Figure 2.

photo 1.